A2 Milk Company Limited · NZX:ATM

A2 Milk — The a2 Milk Company — Shareholder Meeting (November 2026)

34 slides from A2 Milk's shareholder meeting presentation, Nov 19, 2026

  1. Slide 1: 2026 Annual Meeting

    The a2 Milk Company Limited 2026 ANNUAL MEETING We pioneer the future of Dairy for good 19 November 2026

  2. Slide 2: Disclaimer

    Disclaimer This presentation dated 19 November 2026 provides additional While all reasonable care has been taken in relation to the commentary on the financial results for the 12 months ended preparation of this presentation, none of the Company, its 30 June 2026 of The a2 Milk Company Limited (the

  3. Slide 3: Welcome

    Welcome Pip Greenwood 3

  4. Slide 4: Directors and management attending Annual Meeting

    Directors and management attending Annual Meeting Pip Greenwood Grant Dempsey Lain Jager Kate Mitchell Tonet Rivera Sandra Yu Director Director Director Director Director Director Chair of Board Chair of Audit & Risk Chair of People & of Directors Management Committee Remuneration Committee David Bo

  5. Slide 5: Agenda

    Agenda Welcome 3 Chair speech 6 Managing Director & CEO address 8 Formal business 24 Questions 30 Close 31 5

  6. Slide 6: Chair speech

    Chair speech Pip Greenwood 6

  7. Slide 7: Chair speech and key messages

    Chair speech and key messages 1 FY26 performance Solid financial performance despite fourth quarter supply chain disruption Supply chain transformation 2 Acquisition of a2 Pōkeno and commenced insourcing of a2 Platinum manufacturing China growth strategy 3 SAMR approval secured and two new China lab

  8. Slide 8: MD & CEO address

    MD & CEO address David Bortolussi 8

  9. Slide 9: Solid full year results with significant strategic progress

    Solid full year results with significant strategic progress 1 Delivered FY26 results in line with, or slightly ahead of, updated April guidance with double digit revenue growth - Achieved Infant Milk Formula (IMF) growth of 5% in a flat China IMF market - Generated high growth in Other Nutritionals

  10. Slide 10: Double digit revenue growth, margins impacted by supply chain disruption

    Double digit revenue growth, margins impacted by supply chain disruption Continuing operations1 (FY26 versus FY25) Key financials1 Revenue; $ millions • Revenue up 12.4% to $1,974.9 million • EBITDA down 2.5% to $284.4 million − Underlying2 EBITDA up 5.4% to $307.6 million • EBITDA % margin 14.4% do

  11. Slide 11: All geographic and product segments in growth

    All geographic and product segments in growth Group performance1 Segment and product sales1 Segment sales; $ millions Sales up 12.4% with growth from core product portfolio and recent innovation, plus slightly benefiting from FX tailwinds (weakened NZD) Segment performance • China & Other Asia segme

  12. Slide 12: Supply chain disruption in 4Q26 resolved but impacted market share

    Supply chain disruption in 4Q26 resolved but impacted market share China label IMF supply chain disruption a2 至初 market share impacted in 4Q26 • a2 至初 in-market product availability during 4Q26 was materially • In-market product availability necessitated a large proportion of impacted by a number of

  13. Slide 13: Actions underway to recover market share progressing

    Actions underway to recover market share progressing 1Q27 2Q27 3Q27 4Q27 • Introduce market leading traceability tool with batch-by-batch testing Completed 1. Rebuild trust • Amplify through social media and PR campaigns Completed • Engage and refine plan with distributors and key retail partners Co

  14. Slide 14: Brand investment and careful trade management supporting recovery

    Brand investment and careful trade management supporting recovery Commentary on IMF recovery to date Born to love campaign • Brand sentiment and NPS at prior levels supported by significant investment in integrated marketing • RED search index for a2 至初 and a2 Platinum above prior levels in October

  15. Slide 15: FY27 Outlook

    FY27 Outlook a2MC’s revenue and EBITDA are expected to grow in FY27, supported by increased contribution from product innovation and new markets, continued momentum in Other Nutritionals and Liquid Milk, and a2 Pōkeno profitability improvement, with total IMF sales expected to be broadly similar to

  16. Slide 16: Strategy remains focused on capturing China IMF potential

    Strategy remains focused on capturing China IMF potential while ramping up innovation, entering new markets and transforming supply chain Purpose We pioneer the future of Dairy for good Vision An A1-free world where Dairy nourishes all people and our planet CONSUMERS PEOPLE PLANET SHAREHOLDERS Bring

  17. Slide 17: Expect to achieve $2bn revenue ambition by FY27

    Expect to achieve $2bn revenue ambition by FY27 Medium-term revenue and EBITDA margin ambition Areas of planned revenue growth Commentary Revenue, NZ$ billions EBITDA margin • The Company expects to achieve its Growth ambition EBITDA margin target in the teens targeting year-on-year improvement (com

  18. Slide 18: Substantial long-term growth opportunities beyond FY27

    Substantial long-term growth opportunities in core business, adjacent categories and new markets beyond FY27 Market/category size; Retail sales value; FY26; $ billions1 Total combined market size ~$80 bn Total combined addressable market size ~$50 bn a2MC average share of total market ~4% China IMF

  19. Slide 19: Accelerated innovation driving sales growth opportunities

    Accelerated innovation driving sales growth opportunities IMF portfolio expansion to ramp up from FY27 Other Nutritionals innovation expanding growth beyond IMF Innovation and portfolio expansion has been enabled by internal Supported by internal capability and a growing network of product developme

  20. Slide 20: Innovation supported by scientific leadership in A1 protein free dairy

    Innovation supported by scientific leadership in A1 protein free dairy More than 25 years of research in A1 protein free dairy underpins a2MC’s pioneering category leadership • Ongoing investment in science and research supports future product innovation, category expansion and long-term competitive

  21. Slide 21: Continuing growth in new markets with Vietnam starting to scale

    Continuing growth in new markets with Vietnam starting to scale Strong Vietnam performance Growing awareness and distribution Emerging markets future potential Vietnam net sales revenue • Strengthened a2 brand awareness Vietnam through digital campaigns, science • Further distribution expansion of a

  22. Slide 22: Supply chain transformation substantially progressed at a2 Pōkeno

    Supply chain transformation substantially progressed at a2 Pōkeno a2 Pōkeno to unlock significant value, with progress on track The Company successfully completed the acquisition of a2 Pōkeno, a world class nutritional facility, and divestment of MVM, as announced in August 20251. The acquisition si

  23. Slide 23: Continued investment in making planet positive progress

    Continued investment in making planet positive progress • Commenced work to convert gas-fired boiler at a2 Pōkeno to an electrode boiler, advancing progress towards the Company’s Scope 1 & 2 net zero target by 2030 • Established on farm data collection approaches across New Zealand, Australian and U

  24. Slide 24: Formal business

    Formal business Pip Greenwood 24

  25. Slide 25: Notice of Meeting and voting instructions

    Notice of Meeting and voting instructions 25

  26. Slide 26: Resolution 1: Auditor's fees and expenses

    Resolution 1 Auditor’s fees and expenses 26

  27. Slide 27: Resolution 2: Re-election of Director Kate Mitchell

    Resolution 2 Re-election of Director Kate Mitchell 27

  28. Slide 28: Resolution 3: Grant of Rights to David Bortolussi

    Resolution 3 Grant of Rights to David Bortolussi, Managing Director & CEO 28

  29. Slide 29: Polls

    Polls 29

  30. Slide 30: Questions

    Questions 30

  31. Slide 31: Close

    Close Pip Greenwood 31

  32. Slide 32: Appendix

    4g ny ‘a cod wv s re) ” a “ Set ia THe pit Appendix 32

  33. Slide 33: a2MC glossary of terms

    a2MC glossary of terms Acronym Meaning Acronym Meaning 3PMs Third party manufacturers MAT Moving annual total a2MC The a2 Milk Company Limited MBS Mother & baby stores ANZ Australia and New Zealand MVM Mataura Valley Milk Limited CL China label NPAT Net profit after tax DOL Domestic online channel N

  34. Slide 34: www.thea2milkcompany.com

    www.thea2milkcompany.com 34

The a2 Milk Company — Shareholder Meeting (November 2026) on 6ix